CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kukjeon Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kukjeon Pharmaceutical Co Ltd
Daishin Finance Center
343, Samil-daero, Jung-gu
Phone: +82 234862246p:+82 234862246 ANYANG, 14056  South Korea Ticker: 307750307750
Business Summary
Kukjeon Pharmaceutical Co Ltd, formerly Daishin Balance No.6 Special Purpose Acquisition Co Ltd, is a Korea-based company mainly engaged in the manufacture and sale of drug substances. The Company manufactures and sells raw materials used in specialized medicines such as choline alfoscerates, benfothiamines, spherical sorbents, and napamostat mesylatse. The Company sells its products in domestic and overseas markets such as Japan.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jong HoHong 51
Managing Director Jong HakLee 52
Assistant Managing Director Hak SeonKim 52
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 162 (As of 12/31/2023)
Outstanding Shares: 49,069,152 (As of 12/31/2023)
Shareholders: 49,463
Stock Exchange: KDQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024